Ocuphire Pharma
improvement in functional near vision | Ocuphire Pharma
Company
Deck Type
Deck date
January 2022
Slide
93 of 114
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Day
January 2022
post efficacy across presbyopia ages wey | Ocuphire Pharma
Investor Day
January 2022
letter gain in with at hours | Ocuphire Pharma
Investor Day
January 2022
meets planned efficacy at hours | Ocuphire Pharma
Related slides by other companies
Oculis
Results
August 2023
consistent results with in optimize trials | Oculis
Compass Therapeutics
Investor Presentation
May 2023
phase data responses achieved across multiple subclasses as of compass | Compass Therapeutics
BioAtla
Investor Presentation
August 2022
phase trial design for cab naked antibody | BioAtla
AstraZeneca
Results
November 2024
bronchiectasis | AstraZeneca
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights